Coverage
-
October 11, 2013
A New York judge on Wednesday denied Novartis Pharmaceuticals Corp.'s bid for a mistrial declaration in litigation over jaw deterioration injuries purportedly linked to bone drug Zometa, but slashed a $10 million punitive damage award to just less than $1 million.
1 other articles on this case.
View all »